MINI REVIEW article

Front. Digit. Health

Sec. Personalized Medicine

Volume 7 - 2025 | doi: 10.3389/fdgth.2025.1558180

Next Generation Performance Status: Digital Health Technologies Across the Lung Cancer Continuum

Provisionally accepted
  • Weill Cornell Medicine, Cornell University, New York, United States

The final, formatted version of the article will be published soon.

Lung cancer survival rates have greatly benefited from recent advances in therapies and screening. New digital health technologies offer clinicians another way to personalize and enhance care for these patients. For example, emerging technologies support continuous assessment of patients' functional capacity and provide real-time health feedback, improving management of chronic symptoms and monitoring of health trajectory. This review explores these advancements and their potential applications across the lung cancer continuum.

Keywords: functional capacity, performance status, Cardiopulmonary health, lung cancer, Digital Health, wearables

Received: 09 Jan 2025; Accepted: 04 Jun 2025.

Copyright: © 2025 Scarpa, Hussain, Cheng, Villena-Vargas, Altorki and Boyer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Julia Scarpa, Weill Cornell Medicine, Cornell University, New York, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.